See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Vicky Tagalakis

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	38262288	0	Abdulrehman J, Harrigan A, Simard C, et al. TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey. Thromb Res. 2024 Jan 17;235:11-14. doi: 10.1016/j.thromres.2024.01.009.
	37589970	0	Gulati S, Hsu CY, Shah S, et al. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol. 2023 Aug 17. doi: 10.1001/jamaoncol.2023.2934.
	37183930	0	Aloe S, Filliter C, Salmasi S, et al. SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study. Br J Clin Pharmacol. 2023 May 15. doi: 10.1111/bcp.15787.
	37121015	0	Potere N, Di Nisio M, Porreca E, et al. Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial. Thromb Res. 2023 Apr 26;226:82-85. doi: 10.1016/j.thromres.2023.04.015.
	36150513	0	Douros A, Basedow F, Cui Y, et al. Effectiveness and safety of direct oral anticoagulants among octogenarians with venous thromboembolism: an international multi-database cohort study. Am J Med. 2022 Sep 20. pii: S0002-9343(22)00666-0. doi: 10.1016/j.amjmed.2022.08.033.
	36100263	0	Auer RC, Ott M, Karanicolas P, et al. Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ. 2022 Sep 13;378:e071375. doi: 10.1136/bmj-2022-071375.
	36051542	0	Simard C, Gerstein L, Cafaro T, et al. Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature. Res Pract Thromb Haemost. 2022 Aug 29;6(6):e12801. doi: 10.1002/rth2.12801. eCollection 2022 Aug.
	35660801	0	Brandt W, Brown C, Wang TF, et al. Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. Thromb Res. 2022 May 29;216:8-10. doi: 10.1016/j.thromres.2022.05.014.
	35587536	0	Popov J, Coelho S, Carrier M, et al. Step down to six months of prophylactic-dose low-molecular-weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): a pilot study. J Thromb Haemost. 2022 May 19. doi: 10.1111/jth.15760.
	35036824	0	Douros A, Basedow F, Cui Y, et al. Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi-database cohort study. Res Pract Thromb Haemost. 2022 Jan 10;6(1):e12643. doi: 10.1002/rth2.12643. eCollection 2022 Jan.
	34940092	0	Carrier M, Blais N, Crowther M, et al. Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus. Curr Oncol. 2021 Dec 18;28(6):5434-5451. doi: 10.3390/curroncol28060453.
	34000493	0	Rahme E, Godin R, Nedjar H, et al. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study. Thromb Res. 2021 Jul;203:121-130. doi: 10.1016/j.thromres.2021.05.005. Epub 2021 May 11.
	33836492	0	Douros A, Filliter C, Azoulay L, et al. Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism. Thromb Res. 2021 Jun;202:128-133. doi: 10.1016/j.thromres.2021.03.026. Epub 2021 Mar 29.
	33486321	0	Ayele HT, Brunetti VC, Renoux C, et al. Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials. Thromb Res. 2021 Mar;199:123-131. doi: 10.1016/j.thromres.2020.12.029. Epub 2021 Jan 6.
	33160117	0	Payne JG, Tagalakis V, Wu C, et al. Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis. Thromb Res. 2021 Jan;197:8-12. doi: 10.1016/j.thromres.2020.10.030. Epub 2020 Nov 1.
	32723607	0	Malhame I, Tagalakis V, Dayan N. Diagnosing Pulmonary Embolism in Pregnancy: Synthesis of Current Guidelines and New Evidence. J Obstet Gynaecol Can. 2020 Dec;42(12):1546-1549. doi: 10.1016/j.jogc.2020.03.025. Epub 2020 Apr 28.
	31129575	0	Kahn SR, Diendere G, Morrison DR, et al. Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019 May 24;9(5):e024444. doi: 10.1136/bmjopen-2018-024444.
	30545613	0	Tagalakis V. Sex may matter when it comes to the presenting location of deep vein thrombosis. Thromb Res. 2019 Jan;173:164-165. doi: 10.1016/j.thromres.2018.12.001. Epub 2018 Dec 6.
	30511879	0	Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4.
	30262383	0	Laskov I, Kessous R, Abitbol J, et al. Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature. J Obstet Gynaecol Can. 2018 Dec;40(12):1571-1579. doi: 10.1016/j.jogc.2018.04.003. Epub 2018 Sep 24.
	29687454	0	Kahn SR, Morrison DR, Diendere G, et al. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Cochrane Database Syst Rev. 2018 Apr 24;4:CD008201. doi: 10.1002/14651858.CD008201.pub3.
	29353682	0	van Es N, Louzada M, Carrier M, et al. Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9.
	29320795	0	Klil-Drori AJ, Tagalakis V. Direct Oral Anticoagulants in End-Stage Renal Disease. Semin Thromb Hemost. 2018 Jun;44(4):353-363. doi: 10.1055/s-0037-1621715. Epub 2018 Jan 10.
	29132688	0	Klil-Drori AJ, Coulombe J, Suissa S, et al. Temporal trends in outpatient management of incident pulmonary embolism and associated mortality. Thromb Res. 2018 Jan;161:111-116. doi: 10.1016/j.thromres.2017.10.026. Epub 2017 Nov 6.
	28479313	0	Godin R, Marcoux V, Tagalakis V. Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism. Vascul Pharmacol. 2017 Aug;93-95:1-5. doi: 10.1016/j.vph.2017.05.001. Epub 2017 May 4.
	28382493	0	Larivee N, Suissa S, Coulombe J, et al. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters. Drug Saf. 2017 Jul;40(7):583-596. doi: 10.1007/s40264-017-0525-2.
	28160670	0	Coyle K, Carrier M, Lazo-Langner A, et al. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism. Thromb Res. 2017 Mar;151:67-71. doi: 10.1016/j.thromres.2017.01.007. Epub 2017 Jan 25.
	27318246	0	Ma K, Wells P, Guzman C, et al. A multicenter prospective study of risk factors and treatment of unusual site thrombosis. Thromb Res. 2016 Aug;144:100-5. doi: 10.1016/j.thromres.2016.04.014. Epub 2016 Apr 26.
	26947569	0	Sabapathy CA, Djouonang TN, Kahn SR, et al. Incidence Trends and Mortality from Childhood Venous Thromboembolism: A Population-Based Cohort Study. J Pediatr. 2016 May;172:175-180.e1. doi: 10.1016/j.jpeds.2016.02.017. Epub 2016 Mar 3.
	26819144	0	Tagalakis V, Eberg M, Kahn S, et al. Use of statins and reduced risk of recurrence of VTE in an older population. A population-based cohort study. Thromb Haemost. 2016 Jun 2;115(6):1220-8. doi: 10.1160/TH15-10-0775. Epub 2016 Jan 28.
	26817957	0	Ihaddadene R, Corsi DJ, Lazo-Langner A, et al. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism. Blood. 2016 Apr 21;127(16):2035-7. doi: 10.1182/blood-2015-11-682963. Epub 2016 Jan 27.
	26138040	0	Klil-Drori AJ, Yin H, Tagalakis V, et al. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism. Eur Urol. 2016 Jul;70(1):56-61. doi: 10.1016/j.eururo.2015.06.022. Epub 2015 Jun 29.
	26095467	0	Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22.